OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VNP57

5N Plus Inc

Specialty ChemicalsVerified

5N Plus Inc has a debt-to-equity ratio of 0.7 and a current ratio of 2.76, indicating a relatively strong liquidity position with sufficient short-term assets to cover liabilities. The company's return on equity of 25.41% and return on assets of 10.64% suggest strong profitability relative to its equity and asset base. These returns are well above the typical thresholds for the specialty chemicals industry, which often sees ROE in the 10-15% range and ROA in the 5-8% range. The company's revenue is concentrated in a few key markets, with the semiconductor industry being a primary driver of demand. This concentration exposes the company to cyclical fluctuations in the semiconductor sector, which can impact revenue stability. The company's growth trajectory is positive, with a strong operating cash flow of $67.39 million and free cash flow of $47.13 million, which provides flexibility for reinvestment or shareholder returns. The risk assessment indicates a medium liquidity risk due to the company's negative net cash position after subtracting total debt. While the dilution risk is currently low, the company's capital structure and potential for future financing needs should be monitored for any changes in dilution potential. Recent events, including analyst estimates and price targets, suggest a generally positive outlook from the investment community, with a mean price target of $38.40 and a median price target of $37.75.

30-day price · VNP+9.50 (+26.6%)
Low$30.17High$46.00Close$45.28As of25 May, 00:00 UTC
Profile
Company5N Plus Inc
TickerVNP.TO
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. 5N Plus Inc is a specialty chemicals company that produces high-purity materials for the semiconductor, pharmaceutical, and industrial markets.

Classification. The company is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 92% confidence.

5N Plus Inc has a debt-to-equity ratio of 0.7 and a current ratio of 2.76, indicating a relatively strong liquidity position with sufficient short-term assets to cover liabilities. The company's return on equity of 25.41% and return on assets of 10.64% suggest strong profitability relative to its equity and asset base. These returns are well above the typical thresholds for the specialty chemicals industry, which often sees ROE in the 10-15% range and ROA in the 5-8% range. The company's revenue is concentrated in a few key markets, with the semiconductor industry being a primary driver of demand. This concentration exposes the company to cyclical fluctuations in the semiconductor sector, which can impact revenue stability. The company's growth trajectory is positive, with a strong operating cash flow of $67.39 million and free cash flow of $47.13 million, which provides flexibility for reinvestment or shareholder returns. The risk assessment indicates a medium liquidity risk due to the company's negative net cash position after subtracting total debt. While the dilution risk is currently low, the company's capital structure and potential for future financing needs should be monitored for any changes in dilution potential. Recent events, including analyst estimates and price targets, suggest a generally positive outlook from the investment community, with a mean price target of $38.40 and a median price target of $37.75.
Key takeaways
  • 5N Plus Inc has a strong liquidity position with a current ratio of 2.76.
  • The company's return on equity of 25.41% is significantly higher than the industry median.
  • Revenue concentration in the semiconductor industry poses cyclical risk.
  • Analysts have a generally positive outlook, with a mean price target of $38.40.
  • The company's free cash flow of $47.13 million provides flexibility for growth or shareholder returns.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's gross margin of 30.05% and operating margin of 19.04% suggest strong cost control and pricing power, which are expected to be maintained in the near term.",
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$391.1M
Gross profit$117.5M
Operating income$74.4M
Net income$50.6M
R&D
SG&A
D&A
SBC
Operating cash flow$67.4M
CapEx-$20.8M
Free cash flow$47.1M
Total assets$475.1M
Total liabilities$276.2M
Total equity$199.0M
Cash & equivalents$59.6M
Long-term debt$140.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$199.0M
Net cash-$80.4M
Current ratio2.8
Debt/Equity0.7
ROA10.6%
ROE25.4%
Cash conversion1.3%
CapEx/Revenue-5.3%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricVNPActivity
Op margin19.0%8.0% medp25 -2.2% · p75 23.4%above median
Net margin12.9%5.5% medp25 -3.8% · p75 18.5%above median
Gross margin30.0%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-5.3%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity70.0%37.1% medp25 10.3% · p75 82.0%above median
Observations
IR observations
Mean price target38.40 USD
Median price target37.75 USD
High price target46.38 USD
Low price target35.00 USD
Mean recommendation2.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count5.00
Hold count0.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate0.66 USD
Last actual EPS0.56 USD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-25 03:19 UTC#2cc4e3f6
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 23:15 UTCJob: 111ea5c4